Fang, Q., Lu, M., Chen, D., Xie, L., Hong, W., Zhang, Z., & Hu, X. (2025). Targeting SARS-CoV-2 Mpro and PLpro by Repurposing Clinically Approved Drugs. Viruses (1999-4915), 17(12), 1564. https://doi.org/10.3390/v17121564
Chicago Style (17th ed.) CitationFang, Qiaoyu, Meng Lu, Derong Chen, Liangxu Xie, Wenxu Hong, Zhang Zhang, and Xuqiao Hu. "Targeting SARS-CoV-2 Mpro and PLpro by Repurposing Clinically Approved Drugs." Viruses (1999-4915) 17, no. 12 (2025): 1564. https://doi.org/10.3390/v17121564.
MLA (9th ed.) CitationFang, Qiaoyu, et al. "Targeting SARS-CoV-2 Mpro and PLpro by Repurposing Clinically Approved Drugs." Viruses (1999-4915), vol. 17, no. 12, 2025, p. 1564, https://doi.org/10.3390/v17121564.
Warning: These citations may not always be 100% accurate.